Atlas Trials

A Study of LY3023414 in Japanese Participants With Advanced Cancer

Clinical trial NCT02536586 · COMPLETED

Trial details

NCT number
NCT02536586
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Neoplasm
Start date
2015-09-01
Primary completion
2017-02-09
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.